Department of Abdominal Surgery, Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100021, China;
Department of General Surgery, Aerospace Central Hospital, Beijing 100049, China.
Chin J Cancer Res. 2013 Dec;25(6):735-42. doi: 10.3978/j.issn.1000-9604.2013.12.03.
To explore the prognostic relevance of the number and ratio of metastatic lymph nodes in resected Carcinoma of the ampulla of Vater (CAV).
The clinical data of 155 patients who underwent pancreaticoduodenectomy (PD) for cancer of the ampulla of Vater between January 1990 and December 2010 were retrospectively analyzed. Kaplan-Meier method was used in survival analysis and Log rank method in comparison. Multivariate analysis was performed using Cox proportional hazards model.
Among these 155 patients, the in-hospital mortality rate was 4.5%, lymph node positive disease was 21.3%, and the 5-year survival rate was 51.6%. Patients with a lymph node ratio (LNR) >20% were more likely to have tumor differentiation, depth of duodenal involvement, depth of pancreatic invasion, T-stage and TNM-Stage. The number of the metastatic lymph nodes is important prognostic factors of the CAV. Univariate analysis showed that the factors associated with the prognosis included tumor size (P=0.036), tumor differentiation (P=0.019), LNR (P=0.032), number of metastatic lymph nodes (P=0.024), lymph node metastasis (P=0.03), depth of pancreatic invasion (P=0.001), T-stage (P=0.002), TNM stage (P=0.001), elevated CA 19-9 (P=0.000), and jaundice (P=0.021). Multivariate analysis showed that the factors associated with the prognosis were the number of metastatic lymph nodes (P=0.032; RR: 1.283; 95% CI: 1.022-1.611), tumor size (P=0.043; RR: 1.736; 95% CI: 1.017-2.963), and elevated CA 19-9 (P=0.003; RR: 3.247; 95% CI: 1.504-7.010).
LNR is a useful factor for predicting the prognosis of the radical treatment for CAV, whereas the number of metastatic lymph nodes is the most important factor. Further research on the locations, number, and LNR will be clinically meaningful to improve survival in patients with CAV.
探讨切除性 Vater 壶腹癌(CAV)中转移性淋巴结数量和比例的预后相关性。
回顾性分析 1990 年 1 月至 2010 年 12 月期间 155 例接受胰十二指肠切除术(PD)治疗的 Vater 壶腹癌患者的临床资料。采用 Kaplan-Meier 法进行生存分析,采用 Log rank 法进行比较。采用 Cox 比例风险模型进行多因素分析。
在这 155 例患者中,住院死亡率为 4.5%,淋巴结阳性疾病为 21.3%,5 年生存率为 51.6%。LNR>20%的患者更有可能出现肿瘤分化、十二指肠侵犯深度、胰腺侵犯深度、T 分期和 TNM 分期。转移性淋巴结数量是 CAV 的重要预后因素。单因素分析表明,与预后相关的因素包括肿瘤大小(P=0.036)、肿瘤分化(P=0.019)、LNR(P=0.032)、转移性淋巴结数量(P=0.024)、淋巴结转移(P=0.03)、胰腺侵犯深度(P=0.001)、T 分期(P=0.002)、TNM 分期(P=0.001)、CA19-9 升高(P=0.000)和黄疸(P=0.021)。多因素分析显示,与预后相关的因素包括转移性淋巴结数量(P=0.032;RR:1.283;95%CI:1.022-1.611)、肿瘤大小(P=0.043;RR:1.736;95%CI:1.017-2.963)和 CA19-9 升高(P=0.003;RR:3.247;95%CI:1.504-7.010)。
LNR 是预测 CAV 根治性治疗预后的有用因素,而转移性淋巴结数量是最重要的因素。进一步研究转移性淋巴结的位置、数量和 LNR 对提高 CAV 患者的生存率具有临床意义。